Results 241 to 250 of about 50,773 (265)

Janus Kinase (JAK) Inhibitors

2022
Courtney E. Heron, Lindsay C. Strowd, Steven R. Feldman   +2 more
openaire   +1 more source

Phase 2 randomized, dose-ranging trial of CTP-543, a selective Janus Kinase inhibitor, in moderate-to-severe alopecia areata

Journal of the American Academy of Dermatology, 2022
Brett KING, Natasha Atanaskova Mesinkovska, Maria Colavincenzo   +2 more
exaly  

Real-world safety and clinical response of Janus kinase inhibitor upadacitinib in the treatment of hidradenitis suppurativa: A retrospective cohort study

Journal of the American Academy of Dermatology, 2022
John W Frew
exaly  

Synthesis of a Janus Kinase Inhibitor

Synfacts, 2020
openaire   +1 more source

Effect of Janus Kinase Inhibitor Treatment on Anterior Uveitis and Associated Macular Edema in an Adult Patient with Juvenile Idiopathic Arthritis

Ocular Immunology and Inflammation, 2019
Arnd Heiligenhaus, Carsten Heinz
exaly  

Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib

Journal of the American Academy of Dermatology, 2017
Brooke E Rothstein, Deep Joshipura, Rana Abdat   +2 more
exaly  

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial

Lancet, The, 2018
Philip J Mease, Laura C Coates, Philip S Helliwell   +2 more
exaly  

Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study

Journal of the American Academy of Dermatology, 2020
Osamu Nemoto, Atsuyuki Igarashi, Hidehisa Saeki   +2 more
exaly  

Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate

Journal of the American Academy of Dermatology, 2015
Brett KING
exaly  

Effects of Janus kinase inhibitor tofacitinib on circulating serum amyloid A and interleukin-6 during treatment for rheumatoid arthritis

Clinical and Experimental Immunology, 2014
K Migita, Migita K, Kawakami A
exaly